Teva-Lisinopril/Hctz (Type Z) 12.5 mg

Teva-Lisinopril/HCTZ (Type Z) 12.5 mg tablets combine lisinopril and hydrochlorothiazide for blood pressure management. This oral medication is designed to support cardiovascular health by promoting fluid balance and reducing blood pressure.

Teva-Lisinopril/HCTZ (Type Z) 12.5 mg tablets are commonly used to manage high blood pressure, or hypertension. This combination medication works by reducing fluid retention and relaxing blood vessels, which can help lower blood pressure levels. It is often prescribed for individuals who require both an ACE inhibitor and a diuretic to achieve optimal blood pressure control.

Common effects of Teva-Lisinopril/HCTZ (Type Z) 12.5 mg tablets may include dizziness, fatigue, and mild nausea. Some users may experience a dry cough or changes in electrolyte levels. These effects vary among individuals and typically subside as the body adjusts to the medication.

Teva-Lisinopril/HCTZ (Type Z) 12.5 mg tablets should be handled with care, especially for individuals with kidney or liver conditions. It is important to stay hydrated and monitor electrolyte levels while using this medication. Always consult a healthcare provider before starting or stopping this treatment.

Teva-Lisinopril/HCTZ (Type Z) 12.5 mg tablets may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), potassium supplements, and other blood pressure medications. Alcohol and certain dietary supplements may also affect the efficacy of this medication. Always inform your healthcare provider of all medications and supplements you are taking.